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To the Editor,
Although primary antibody deficiencies may be associated
with undernutrition, there is just one published study on the
nutritional status of patients with primary immunodeficiencies
[1]. Kouhkan et al. studied 38 patients with different primary
immunodeficiencies and showed that 21 % of them were un-
derweight, 8 % overweight and 3 % obese [1].
Between April 2012 and November 2014, we evaluated the
nutritional status of 73 patients (71 males) with X-linked
(XLA, n = 67) or autosomal recessive agammaglobulinemia
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(ARA, n= 6) followed at 14 Centers of the Italian Primary
Immunodeficiency Network (IPINet). All patients were un-
dergoing appropriate immunoglobulin replacement therapy
according to international guidelines [2]. In ARA patients,
mutations in genes encoding for μ heavy chain, Igα, Igβ
and λ5 were evaluated. The 2 ARA girls had the same homo-
zygous mutation for the μ heavy chain and the 4 ARA boys
had no detectable mutation.
Weight, length (< 2 years of age) or height (≥ 2 years of
age) were measured and body mass index (BMI) was calcu-
lated [3]. Standard deviations scores (SDS) of weight-for-age,
length-for-age, height-for-age and BMI-for-age were calculat-
ed using the World Health Organization (WHO) reference
data [4]. For patients aged 0 to 19 years, values of BMI
SDS < −2.0, − 2.0 to 1.0, > 1.0 to 2.0, and >2.0 were used
to diagnose underweight, normal weight, overweight and obe-
sity, respectively. For patients aged >19 years, BMI was eval-
uated according to the WHO guidelines for adults [3].
Stunting was defined as a length or height < 2.0 SDS [4].
The anthropometric measurements of the patients at the
study visit are given in Table 1. Blood samples were collected
in order to evaluate IGF-1, prealbumin, albumin, transferrin,
glucose, insulin, total cholesterol, HDL cholesterol, LDL cho-
lesterol, apolipoprotein A, apolipoprotein B and triglycerides.
Among the 41 patients aged >19 years at the study visit, 3
(7 %) were underweight, 26 (63 %) had a normal weight, 11 (27 %) were overweight and 1 (2 %) was obese. The first
undernourished patient had no complications. The second un-
dernourished patient had chronic obstructive pulmonary dis-
ease (COPD) and chronic sinusitis. The third undernourished
patient had severe thinness (BMI < 16.0 kg/m2), anemia and
hypoalbuminemia (3.1 mg/dl), and was treated with parenteral
nutrition. Evidence of a chronic inflammatory infiltrate at je-
junal biopsy in this patient suggested infection with
Microsporidium, which was treated following standard guide-
lines. The hypoalbuminemia of this patient was the only in-
stance of an altered laboratory marker of nutritional status
identified during the study. In fact all other nutritional indexes
were within the normal limits according to the different labo-
ratory settings. Among the 32 patients aged ≤19 years at the
study visit,1 (3 %) was underweight, 15 (47 %) had a normal
weight, 8 (25 %) were overweight and 8 (25 %) were obese.
Moreover, 3 of them were (9 %) stunted. No other patient
reported intestinal malabsorption and/or gastrointestinal prob-
lems. All patients had no evidence of endocrine or pubertal
disease.
COPD, the most frequent complication of agammaglobu-
linemia, was present in 22 (30 %) of our 73 patients, mostly in
those aged ≥19 years. Its appearance would be independent of
nutritional status. For 44 patients, we were able to retrieve the
anthropometric measurements performed when agammaglob-
ulinemia was diagnosed and compared them with the anthro-
pometric measurements performed at the study time. The me-
dian duration of follow-up for these 44 patients was 17 years.
Table 1 Anthropometric measurements at the study visit
N Level Value
Age (years), mean (SD) 73 22 (11)
Weight (kg), mean (SD) 73 61.1 (21.2)
Weight-for-age
(SDS WHO), mean (SD)
11 0.88 (0.95)
Height (m), mean (SD) 72 1.63 (0.21)
Height-for-age
(SDS WHO), mean (SD)
31 0.08 (1.10)
Length (m), mean (SD) 1 0.86 (NA)
Length-for-age
(SDS WHO), mean (SD)
1 0.5 (NA)
BMI (kg/m2), mean (SD) 73 22.5 (4.7)
BMI-for-age (SDS WHO) 32 0.90 (1.35)
BMI status (WHO), N (%) 73 Underweight 4 (5 %)
Normal weight 41 (56 %)
Overweight 19 (26 %)
Obese 9 (12 %)
SDS of weight-for-age available from 0 to 10 years of age; SDS of length-
for-age available from 0 to 2 years of age; SDS of height-for-age available
from 2 to 19 years of age; SDS of BMI-for-age available from 0 to
19 years of age.
Abbreviations: SD = standard deviation; SDS = standard deviation
scores: WHO = World Health Organization; NA = not available
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Among the 6 patients that were underweight at diagnosis, 1
was underweight, 3 were normal-weight, 2 were overweight
and none was obese at the study time. Among the 18 patients
who were normal-weight at diagnosis, 1 was underweight, 13
were normal-weight, 3 were overweight, and 1 was obese at
the study time. Among the 17 patients whowere overweight at
diagnosis, 1 was underweight, 8 were normal-weight, 6 were
overweight and 2 were obese at the study time. Among the 3
patients who were obese at diagnosis, none was underweight,
1 was normal-weight, 2 were overweight, and none was obese
at the study time.
In this multi-center study of XLA and ARA patients, over-
weight and obesity (38 %) were much more common than
undernutrition (5 %). The low frequency of undernutrition is
at least partly attributable to the appropriate immunoglobulin
replacement therapy, which is known to decrease the occur-
rence of infectious disease and to increase the life expectancy.
The median age at the diagnosis of immunodeficiency was in
fact 2 years, with 3 cases diagnosed prenatally. Early diagno-
sis is the gold standard for primary immunodeficiencies, with
the aim to start therapy as soon as possible in order to reduce
complications and improve quality of life. A limitation of the
present study is the lack of a control group, due to the diffi-
culty of finding healthy children similar to XLA and ARA
patients for age and other features when many tertiary care
centers are involved. Although a direct comparison with pop-
ulation data is unwarranted because our study was performed
in subjects with a rare disease followed by tertiary care cen-
ters, it is certainly of interest that overweight and obesity were
nearly as common in young and adult Italian patients with
XLA and ARA as they are in the general Italian population
[5, 6], but with a trend towards a higher rate of obesity in those
patients aged less than 19 years.
In conclusion, the most interesting finding of this study is
the unexpected high frequency of apparent overnutrition with
excess body weight in a group of XLA and ARA patients. No
one displayed enough features justifying the diagnosis of met-
abolic syndrome.
Low physical activity, partly motivated by an unsubstanti-
ated fear of infection, together with a poor diet and the psy-
chological burden of a chronic illness, may contribute to the
risk of overweight and obesity in these patients. During
follow-up of XLA and ARA patients a nutritional counseling
may be recommended to keep under control the development
of risk factors for cardiometabolic disease. Further surveys are
needed to confirm our observations in order to better investi-
gate the nutritional status (and the body composition, if pos-
sible) in patients with agammaglobulinemia and other primary
immunodeficiencies with the aim of improving their quality of
life.
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